Precision clinical data.
Designed to be used.

Side-by-side adverse effect burden across system organ classes — for individual drugs or full regimens.

Multi-drug interaction screening combining verified clinical databases with DeepDDI machine learning.

Full prescribing information alongside clinical trial adverse-event incidence and FDA FAERS real-world data.

Per-cycle oncology regimen costing from MPR data. Dose-adjusted for BSA, weight, and CrCl with least-cost vial packing.

Cost-effectiveness landscape by condition and treatment setting — comparative regimen costs with survival evidence for managed-care analysis.

Head-to-head regimen outcomes from structured trial data — hazard ratios as forest plots or a sortable evidence table.